Production (Stage)
D
OptimizeRx Corporation OPRX
$12.19 -$0.45-3.56% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Net Income -2,719.23% 99.15% -127.59% 41.89% -66.56%
Total Depreciation and Amortization -35.87% 55.93% 0.00% 0.70% -20.00%
Total Amortization of Deferred Charges 381.82% -79.93% 8.30% 0.00% 272.06%
Total Other Non-Cash Items -64.61% -48.01% 191.76% -8.05% -72.79%
Change in Net Operating Assets 156.34% -590.61% 84.99% -86.27% 130.69%
Cash from Operations 1,851.52% -88.94% 129.03% -63.08% 133.84%
Capital Expenditure -58.82% 5.56% 60.00% -40.63% -540.00%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 44.66% -39.19% -85.00% 66.94% -100.22%
Cash from Investing 30.00% -30.43% -8.24% 44.44% 99.41%
Total Debt Issued -- -- -- -- --
Total Debt Repaid 80.00% -400.00% 0.00% 0.00% 70.76%
Issuance of Common Stock -- -- -- -- --
Repurchase of Common Stock 73.15% -912.50% 92.29% -196.43% 4.11%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 79.21% -430.83% 41.86% -42.97% -101.77%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 216.28% -335.30% 635.32% -116.45% -66.28%